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The Journal of Immunology
TLR-Mediated Inflammatory Responses to Streptococcus
pneumoniae Are Highly Dependent on Surface Expression
of Bacterial Lipoproteins
Gillian Tomlinson,* Suneeta Chimalapati,† Tracey Pollard,† Thabo Lapp,*,1
Jonathan Cohen,†,‡ Emilie Camberlein,†,2 Sian Stafford,† Jimstan Periselneris,†
Christine Aldridge,x Waldemar Vollmer,x Capucine Picard,{,‖ Jean-Laurent Casanova,{,#
Mahdad Noursadeghi,*,3 and Jeremy Brown†,3
Streptococcus pneumoniae infections induce inflammatory responses that contribute toward both disease pathogenesis and im-
munity, but the host–pathogen interactions that mediate these effects are poorly defined. We used the surface lipoprotein-deficient
Δlgt pneumococcal mutant strain to test the hypothesis that lipoproteins are key determinants of TLR-mediated immune responses
toS. pneumoniae.We showusing reporter assays that TLR2 signaling is dependent on pneumococcal lipoproteins, and thatmacrophage
NF-kBactivation andTNF-a releasewere reduced in response to theΔlgt strain.Differences inTNF-a responses betweenDlgt andwild-
type bacteria were abrogated for macrophages from TLR2- but not TLR4-deficient mice. Transcriptional profiling of human macro-
phages revealed attenuated TLR2-associated responses to Δlgt S. pneumoniae, comprising many NF-kB–regulated proinflammatory
cytokine and chemokine genes. Importantly, non-TLR2–associated responses were preserved. Experiments using leukocytes from IL-
1R–associated kinase-4–deficient patients and a mouse pneumonia model confirmed that proinflammatory responses were lipoprotein
dependent. Our data suggest that leukocyte responses to bacterial lipoproteins are required for TLR2- and IL-1R–associated kinase-4–
mediated inflammatory responses to S. pneumoniae. The Journal of Immunology, 2014, 193: 3736–3745.
S
treptococcus pneumoniae pneumonia, meningitis, and sep-
ticaemia are major causes of morbidity and mortality, re-
sponsible for .800,000 childhood deaths per year (1).
S. pneumoniae infections are characteristically associated with in-
flammation (2), including a strong acute-phase response, rapid
leukocyte recruitment to the site of infection, and compromise of
endothelial or epithelial barriers. Although the inflammatory
response is required for host immunity, excessive inflammation
contributes toward serious complications of S. pneumoniae in-
fection, such as neurologic damage, septic shock, and acute lung
injury (3, 4). Characterizing the factors that drive the inflam-
matory response to S. pneumoniae will help explain the patho-
genesis of pneumococcal infections and identify targets for novel
therapies.
TLR are a key mechanism for innate immune sensing and are
important for the host response to S. pneumoniae. Genetic defi-
ciency of TLR signaling pathway proteins substantially increases
the risk of invasive S. pneumoniae infections (5–7). Fifty-four
percent of children with IL-1R–associated kinase 4 (IRAK-4)
deficiency and 41% of patients with MyD88 deficiency have at
least one episode of invasive pneumococcal disease (5, 8–10).
Similarly, mice deficient in the TLR-signaling molecule MyD88
are highly susceptible to S. pneumoniae infections (11, 12).
IRAK-4 deficiency largely prevents inflammatory responses to
purified TLR ligands (6, 7), including expression of the cytokines
TNF-a, IL-1b, and IL-6 that are important for host immunity to
S. pneumoniae (13–15). Although innate immune recognition of
S. pneumoniae is dependent on contributions from several TLRs,
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including TLR2, TLR4, and TLR9 (11, 16–24), the release of
inflammatory cytokines such as TNF-a and IL-6 seems to be
particularly dependent on TLR2 (19–21, 25). TLR2 contributes to
the inflammatory response and control of infection in mouse
models of meningitis and pneumonia (18, 22–24) and has addi-
tional effects that may affect disease development. First, the
proinflammatory effects of TLR4 activation and of the S. pneu-
moniae toxin pneumolysin are partly dependent on synergistic
activation of TLR2 (26, 27). Second, adaptive immune responses
to S. pneumoniae can be impaired in TLR2-deficient mice (19, 28,
29). Third, TLR2-mediated respiratory epithelium responses to
infection by S. pneumoniae increase tight junction breakdown and
bacterial translocation across epithelial layers (30). Hence, iden-
tifying the S. pneumoniae TLR2 ligands is necessary for under-
standing of the molecular mechanisms contributing to disease
pathogenesis by this pathogen.
Known TLR2 ligands include peptidoglycan (PGN) and lip-
oteichoic acid (LTA), both components of the Gram-positive cell
wall (31, 32). The S. pneumoniae cell wall is highly proin-
flammatory, suggesting PGN and LTA could be major TLR2
agonists (33–35). However, cell wall–dependent inflammation is
also mediated by NOD recognition of PGN (36, 37), and purified
S. pneumoniae LTA does not stimulate IL-8 production by
HEK293 cells transfected with TLR2 (38). Hence, cell wall
products may not be dominant TLR2 agonists for S. pneumoniae.
Bacterial lipoproteins are important TLR2 ligands for other Gram-
positive pathogens (32, 39, 40), and S. pneumoniae expresses
a large number of lipoproteins, many of which are important
for bacterial virulence (41–46). However, the importance of
S. pneumoniae lipoproteins for TLR2-mediated immune recogni-
tion and proinflammatory responses has not been investigated. We
have used a S. pneumoniae mutant strain with markedly reduced
surface lipoprotein content due to deletion of the lipoprotein
diacylglyceryl transferase gene lgt (45) to assess the contribution
of lipoproteins to TLR-dependent inflammatory responses to
S. pneumoniae. The effects of lipoproteins on macrophage responses
to S. pneumoniae were characterized in detail using transcriptome
analysis and by measuring important proinflammatory cytokine
responses of mouse macrophages with deletions affecting the TLR
pathway and leukocytes from patients with IRAK-4 deficiency.
Materials and Methods
Ethics statement
Experiments using human cells were approved by the joint University
College London/University College Hospitals National Health Service
Trust Human Research Ethics Committee, and written informed consent
was obtained from all participants. All animal experiments were approved
by the University College London Biological Services Ethical Committee
and the United Kingdom Home Office (Project License PPL70/6510) and
performed according to United Kingdom national guidelines for animal
use and care.
Bacterial strains and growth conditions
The S. pneumoniae strain, TIGR4, was a gift of J. Weiser (University of
Pennsylvania, Philadelphia, PA). The Δlgt strains were obtained by in-
frame deletion of lgt (Sp1412) from wild-type (WT) TIGR4, D39, and
Δpab TIGR4 strains, as previously described (45, 47). Mutant strains were
genome sequenced by the Wellcome Trust Centre for Human Genetics
(Oxford, U.K.) using an Illumina MiSeq sequencer. Sequences were
assembled using Velvet, annotated using Prokka, and mapped to the pub-
lished TIGR4 and D39 (R00000036) reference genomes. Bases and single-
nucleotide variants were identified using the SAMtools “mpileup” command
and BCFtools. Sites were filtered to a minimum depth of five reads at
each and single-nucleotide variant quality of 25, and the Integrated Ge-
nome Viewer was used to visualize mapping and coverage. S. pneumoniae
was cultured overnight at 37˚C in 5% CO2 on Columbia agar (Oxoid)
supplemented with 5% horse blood (TCS Biosciences). Working stocks
grown to an OD of 0.4 (∼108 CFU/ml) were made using Todd-Hewitt broth
supplemented with 0.5% yeast extract and stored at 280˚C in 10% glyc-
erol as single-use aliquots. CFU were confirmed by colony counting of
log10 serial dilutions of bacteria cultured overnight on 5% Columbia blood
agar. Chloramphenicol (10 mg ml21) and kanamycin (500 mg ml21) were
added to blood agar plates where appropriate.
Preparation of bacterial lysates and Triton X-114 extraction of
lipoproteins
Bacterial lysates were made using mid log-phase growth S. pneumoniae
cells by addition of 0.1% deoxycholate (Sigma-Aldrich) in PBS for 30 min
at 37˚C and sonication with a Soniprep 150 (Sanyo) ultrasonicator. Mem-
brane-associated proteins were extracted from lysates by Triton X-114
extraction, as described previously (48, 49), washed, and diluted 1:2 in
PBS prior to solubilization in Laemmli sample buffer for SDS-PAGE and
visualization using Coomassie brilliant blue (Sigma-Aldrich) staining.
Cell isolation and culture
Blood samples were obtained from healthy volunteers or IRAK-4–deficient
subjects homozygous for the Q293X mutation for isolation of PBMC or
production of monocyte-derived macrophage (MDM) by differentiation
with M-CSF, as previously described (50). Bone marrow was extracted
from 6- to 8-wk-old C57BL/6 WT, TLR22/2, TLR42/2 (Jackson Immuno-
Research Laboratories), or Myd88/trif2/2 mice (gift of S. Akira, De-
partment of Host Defense, Research Institute for Microbial Diseases,
Osaka University, Suita, Osaka, Japan) and differentiated into bone mar-
row–derived macrophages (BMDM) for 7 d in L929-conditioned medium
using standard protocols (51, 52). The RAW 264.7 murine macrophage cell
line was cultured as adherent cells in RPMI 1640 (Life Technologies)
supplemented with 2 mM L-glutamine (Invitrogen) and 10% FBS (Life
Technologies).
PGN purification and structural analysis
Pneumococcal cell wall (PGN–teichoic acid complex) and PGN were
prepared, as described (53), and muropeptide was released by digesting
PGN with cellosyl (provided by Hoechst). Muropeptides were reduced
with sodium borodydride and analyzed by high-pressure liquid chroma-
tography, as described (53). The peaks were assigned by comparing their
retention time with the retention time of known muropeptides obtained
from strain R6, whose muropeptide profile is similar to that of strain
TIGR4. Peak 1 (Fig. 3) was collected and analyzed by electrospray mass
spectrometry, as described (53, 54).
Innate immune stimulation, cytokine measurements, and
NF-kB nuclear translocation
HEK TLR2 reporter assays were stimulated with S. pneumoniae for 16 h,
according to the manufacturer’s instructions (Invivogen). White cells were
stimulated as follows for collection of supernatants, RNA isolation, or
NF-kB translocation assays: MDM and PBMC stimulated for 1–24 h with
S. pneumoniae strains at a multiplicity of infection (MOI) of 5–50 or
Pam2CSK4 (100 ng/ml; Axis-Shield); RAW 264.7 cells stimulated with
different S. pneumoniae strains at a MOI of 5 or 10 ml (in a total volume of
300 ml) Triton X-114 extracts for up to 4 h (47); BMDM stimulated with
S. pneumoniae bacterial strains in DMEM without any supplements for 4 h
at a MOI of 5. Cytokine levels were measured in cell culture supernatants
using ELISA (R&D Systems or eBioscience), or the Luminex or MSD
platforms, according to the manufacturer’s instructions. NF-kB activation
was assessed by quantifying nuclear RelA using the MSD system, ac-
cording to the manufacturer’s instructions, or using immunofluorescence
of MDMs to obtain nuclear:cytoplasmic ratios of NF-kB Rel A (p65)
staining as a marker of NF-kB nuclear translocation (50, 55).
Transcriptional profiling by cDNA microarray and quantitative
PCR
Total RNA was purified from cell lysates using the RNEasy mini kit
(Qiagen). Samples were processed for Agilent microarrays, and data were
normalized, as previously described (56). Microarray data are available in
the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under accession
number E-MTAB-1541. For quantitative PCR (qPCR), cDNAwas synthesized
using the qScript cDNA Supermix kit (Quanta BioSciences), and qPCR of
selected genes was performed using the following inventoried TaqMan assays
(Applied Biosystems): IL23 (Hs00372324_m1), IL1b (Hs01555410_m1), IL6
(Hs00985639_m1), and TNFa (Hs00174128_m1). PTSG2 expression was
quantified using the following: forward primer, 59-CGGTCCTGG-
CGCTCAG-39; reverse primer, 59-CCGGGTACAATCGCACTTATACTG-39;
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and probe, 59-CCATACAGCAAATCCTT-39 (Applied Biosystems). Expres-
sion levels of target genes were normalized to GAPDH, as previously de-
scribed (57).
Animal model of lung infection
Six- to 8-wk-old outbred CD1 female white mice (Charles Rivers Breeders)
were inoculated intranasally with 1 3 107 CFU in an inoculum volume of
50 ml under halothane (Zeneca) general anesthesia. Bronchoalveolar la-
vage fluid (BALF) samples were obtained from culled mice 4 h postin-
fection for cytokine assays using ELISAs (R&D Systems), bacterial CFU
by colony counting of serial dilutions plated onto Columbia blood agar
plates containing 5 mg ml21 gentamicin, and total cell counts using
a manual hemocytometer (Gova Glasstic slides; Hycor Biomedical UK)
under light microscopy (original magnification 320) following 1:2 dilu-
tion of BALF in 0.001% crystal violet in acetic acid.
Statistical analysis
Data that would be normally distributed (results of macrophage cytokine
analyses and qPCR) were analyzed using paired (for data obtained from
matched samples) or unpaired (for data obtained from unmatched samples)
t tests. Nonnormally distributed data (data from mouse experiments and
NF-kB nuclear translocation data) were compared using the Mann–Whitney
U test. Principal component (PC) analysis was used to compare global
gene expression profiles, as previously described, and t tests were used to
identify significant gene expression differences (p , 0.05) between sam-
ples using MultiExperiment Viewer v4.6.0 (57). Transcriptional regula-
tion of specific gene signatures was assessed by analysis of single trans-
cription factor binding site enrichment analysis (http://opossum.cisreg.ca/
oPOSSUM3/). Pathway and Gene Ontology overrepresentation analysis
was performed using InnateDB (http://www.innatedb.com/).
Results
TLR2 signaling in response to S. pneumoniae is dependent on
lipoproteins
Triton-X extracts of the TIGR4 Dlgt S. pneumoniae strain con-
firmed that this strain has almost no detectable lipoproteins,
similar to the previously described 0100993 Dlgt strain (Fig. 1A)
(45). A reporter assay was used to assess whether loss of lipo-
proteins significantly affected TLR2 signaling by S. pneumoniae
(Fig. 1B). Live whole TIGR4 WT bacteria stimulated a strong
TLR2-dependent signal, whereas live Dlgt bacteria did not cause
any significant response even with high multiplicities of infection
(MOI). Lysed bacteria gave similar results, demonstrating that
impaired growth or failure of release of nonlipoprotein TLR2
ligands such as PG and LTA was not responsible for the lack of
FIGURE 1. TLR2 activation by S. pneumoniae is dependent on surface lipoproteins. (A) Coomassie blue staining of Triton-X–extracted membrane
proteins from the WT (TIGR4) and TIGR4Dlgt strains separated by SDS-PAGE, confirming markedly reduced lipoprotein content for the Dlgt strain. A
molecular mass marker (15–80 kDa) is also shown. (B and C) Mean relative absorbance (OD650) of supernatants from a TLR2/HEK reporter cell line
incubated for 16 h with different MOI of live (empty columns) or lysed (gray columns, using deoxycholate) (B) TIGR4Dlgt or TIGR4 and (C) D39Dlgt or
D39 S. pneumoniae. Error bars represent SEMs, and n = 3 with data representative of repeated experiments.
FIGURE 2. Macrophage TNF-a responses are dependent on S. pneumoniae lipoproteins. (A and B) Time course of TNF-a concentrations (measured by
ELISA) in RAW cell culture supernatants after incubation with TIGR4 or TIGR4Dlgt S. pneumoniae (MOI 5). (C) TNF-a concentrations in RAW cell
culture supernatants after 4-h incubation with Pam2CSK4, WT, TIGR4Dlgt, TIGR4DpabB, or TIGR4DlgtDpabB S. pneumoniae. Bacterial CFU after 4-h
incubation are stated above each column. (D) TNF-a concentrations in RAW cell culture supernatants after incubation for 4 and 24 h with the TLR agonist
Pam2CSK4, or sonicated TIGR4 or TIGR4Dlgt S. pneumoniae. (E) TNF-a concentrations in RAW cell culture supernatants after 4-h incubation with TIGR4
or TIGR4Dlgt S. pneumoniae or their corresponding 3.3% Triton X-114 lipoprotein. For all panels, n = 3–4 and is representative of repeated experiments,
data are presented as means, error bars represent SEMs, and p values were obtained using unpaired t tests.
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TLR2 response to the Dlgt bacteria. We have not been able to
complement the Dlgt mutation (45); hence, to confirm linkage of
the loss of TLR2 responses to the mutation, we transferred the
mutation to the D39 S. pneumoniae strain and obtained similar
results to the TIGR4 strain, with almost complete loss of TLR2-
dependent signaling to both live and lysed D39Dlgt (Fig. 1C).
Whole-genome sequencing of the Dlgt TIGR4 and D39 S. pneu-
moniae strains was performed to identify unexpected mutations
that might confound the results (Supplemental Table I). Both the
D39 and TIGR4 Dlgt strains contained the expected complete
deletion of lgt (replaced by the kan antibiotic resistance gene), as
well as two synonymous single nucleotide polymorphisms (SNPs)
in the gene immediately downstream of lgt (Spd_1244 and Sp_1413,
respectively) that encodes a Hpr(Ser) kinase/phosphatase. In ad-
dition, the Dlgt TIGR4 strain contained one SNP in a noncoding
intergenic region, and one nonsynonymous SNP changing a histi-
dine for an arginine at position 336 of a 413-aa residue protein
encoded by Sp_2175 (dltB), predicted to be an alanine exporter
involved in lipoteichoic acid synthesis. These data indicate that
loss of TLR2 stimulation was linked to deletion of lgt and suggest
that lipoproteins are major S. pneumoniae TLR2 ligands.
Mouse macrophage TNF-a response to S. pneumoniae is
dependent on lipoproteins
To assess the significance of lipoprotein-dependent TLR2 signaling
on the strength of the inflammatory response to S. pneumoniae,
TNF-a secretion by the RAW mouse macrophage cell line was
compared after incubation with WT or Dlgt TIGR4. Significant
production of TNF-a was evident after 2-h incubation with WT
S. pneumoniae (Fig. 2A), but was significantly attenuated in re-
sponse to the Dlgt strain at 2, 4, and 24 h (Fig. 2A, 2B). Loss of lipo-
proteins affects S. pneumoniae growth (45), and after 4-h incu-
bation with RAW cells there are ∼60% fewer Dlgt bacteria/ml
than the WT strain (Fig. 2C). However, the reduced TNF-a re-
sponse to the Dlgt strain persisted when RAW cells were stimu-
lated with sonicated bacteria (Fig. 2D), and after transfer of the lgt
mutation to the DpabB strain (Fig. 2C), an auxotrophic mutant
that replicates poorly without addition of exogenous para-
aminobenzoic acid (47). Furthermore, there was a similar scale
reduction in the RAW cell TNF-a response to the Dlgt strain when
RAW cells were stimulated with Triton-X extracts for 4 h, pro-
viding further evidence of a direct effect of lipoproteins on in-
flammatory responses (Fig. 2E).
The Dlgt mutation has no effect on PGN structure
As the PGN synthesis enzyme PGN deacetylase is a hypothetical
lipoprotein, PGN structure could potentially be affected by deletion
of lgt (58). However, the muropeptide profile of the Dlgt TIGR4
strain did not significantly differ from that of WT TIGR4, and
both were similar to the reported muropeptide profile of strain R6
(an unencapsulated derivative of D39) (53). Importantly, PGN
from Dlgt TIGR4 contained peaks corresponding to muropeptide
with deacetylated GlcNAc residues, which are generated by PGN
deacetylase (53, 58). To further confirm the presence of deace-
tylated muropeptides in the Dlgt TIGR4 sample, the main
deacetylated monomer (peak 1, Fig. 3) was analyzed by mass
spectrometry (MS). The obtained neutral mass of 783.3880 Da is
consistent with the theoretical mass of 783.3862 Da for the
deacetylated disaccharide tripeptide (GlcN-MurNAc-L-Ala-D-
iGln-L-Lys). The MS/MS fragmentation pattern of this signal
showed the expected loss of a dehydrated glucosamine residue
(160.9152 Da, theoretical 161.0688). Therefore, there are no
significant alterations in PGN structure that could account for
the effects of the Dlgt mutation on inflammatory responses to
S. pneumoniae.
FIGURE 3. Normal muropeptide profile for PGN from the TIGR4Dlgt
strain. HPLC analysis of muropeptides isolated from cell wall preparations
of the TIGR4 and TIGR4Dlgt strains. Major muropeptides are indicated by
numbers, as follows: 1, GlcN-MurNAc-L-Ala-D-iGln-L-Lys; 2, GlcNAc-
MurNAc-L-Ala-D-iGln-L-Lys; 3, GlcNAc-MurNAc-L-Ala-D-iGln-L-Lys-
L-Ser-L-Ala; 4, GlcNAc-MurNAc-L-Ala-D-iGln-L-Lys-D-Ala-L-Lys-D-
iGln-L-Ala-MurNAc-GlcNAc; 5, GlcNAc-MurNAc-L-Ala-D-iGln-L-Lys-
L-Ser-L-Ala-D-Ala-L-Lys-D-iGln-L-Ala-MurNAc-GlcNAc. The structure
of peak 1 (arrow) was confirmed by mass spectrometry. GlcN, glucos-
amine; GlcNAc, N-acetylglucosamine; MurNAc, N-acetylmuramic acid.
FIGURE 4. S. pneumoniae lipoproteins induce proinflammatory cyto-
kines via TLR2 pathway activation. Mean TNF-a concentrations in cell
culture supernatants from BMDMs obtained from C57BL/6 mice incu-
bated for 4 h with the TLR agonists (LPS and/or Pam2CSK4), or TIGR4 or
TIGR4Dlgt S. pneumoniae. (A) Results for BMDMs obtained from WT or
Myd88/trif2/2mice. (B) Results for BMDMs obtained fromWTor TLR22/2
mice. (C) Results for BMDMs obtained from WT or TLR42/2 mice. For all
panels, n = 3–4 and is representative of repeated experiments, error bars
represent SEMs, and p values were obtained using unpaired t tests.
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S. pneumoniae lipoprotein effects on macrophage TNF-a
responses are TLR2 dependent
To investigate whether the differences in TNF-a responses between
the WT and Dlgt strains were attributable to specific TLRs, TNF-a
responses by BMDMs from WT, tlr22/2, tlr42/2, or Myd88/trif2/2
mice were also evaluated. There was no significant TNF-a release
by BMDMs from Myd88/trif2/2 mice incubated with either the
WT or Dlgt strain, showing the necessity of TLR signaling for the
TNF-a response to S. pneumoniae (Fig. 4A). WT TIGR4 induced
significantly greater TNF-a secretion by BMDMs from WT mice
than the Dlgt strain. TNF-a release by BMDMs from tlr22/2 mice
was strongly reduced in comparison with BMDMs from WT mice,
although there was still a residual response compared withMyd88/
trif2/2 BMDMs (Fig. 4A, 4B). Importantly, for BMDMs from
tlr22/2 mice, there was no increased TNF-a response to WT
TIGR4 compared with Dlgt bacteria, indicating that the increase
seen with BMDMs from WT mice was TLR2 dependent. In
contrast, although TNF-a production by BMDMs from tlr42/2
mice was reduced in response to both strains compared with
BMDMs from WT mice, WT TIGR4 still induced significantly
higher levels of TNF-a secretion than the Dlgt strain (Fig. 4C).
These results demonstrate that the TLR2 but not the TLR4 re-
sponse was dependent on bacterial lipoproteins.
Loss of lipoproteins attenuates NF-kB activation in response to
S. pneumoniae
We then assessed whether loss of TLR2 signaling in response to the
Dlgt strain affected activation of the key proinflammatory tran-
scriptional regulator NF-kB (59, 60) in macrophages. Quantifying
NF-kB Rel A in nuclear extracts showed there was a significant
increase in BMDM NF-kB activation by WT TIGR4 that was
largely abrogated in macrophages from Myd88/trif2/2 mice or in
WT BMDMs infected with the Dlgt strain (Fig. 5A). Similarly,
NF-kB activation was significantly attenuated in response to the
Dlgt strain compared with WT TIGR4 when assessed using
a confocal assay to quantify nuclear translocation of NF-kB Rel
A in human MDMs (Fig. 5B, 5C). These data suggest both
mouse and human macrophage NF-kB activation in response to
S. pneumoniae is dependent on TLR recognition of lipoproteins.
Comparison of the macrophage transcriptome to the TIGR4
and Dlgt strains
To provide detailed data on the effect of lipoproteins on global
inflammatory responses to S. pneumoniae, human MDM genome-
wide transcriptional responses were compared after incubation for
4 h with live WT or Dlgt TIGR4 bacteria, or the specific TLR2
agonist Pam2CSK4. All three stimuli caused major changes in
gene expression; Pam2CSK4 and WT TIGR4 stimulated the in-
creased expression of 854 and 936 genes, respectively, with the
Dlgt strain causing upregulated expression of slightly fewer genes
(591 in total) (Fig. 6A, 6B). Although there was a large overlap in
the genes upregulated by Pam2CSK4, WT TIGR4, and the Dlgt
strain, there was greater overlap with Pam2CSK4 for responses to
WT TIGR4 than for Dlgt, in keeping with the hypothesis that
S. pneumoniae lipoproteins are important for TLR2-associated
transcriptional responses.
PC analysis was used to explore differences in cocorrelated gene
expression data. In PC1, which reflects the greatest gene expres-
sion differences between stimulated and unstimulated macrophages,
the effects of WT TIGR4 were equivalent to those of Pam2CSK4.
However, Dlgt-induced changes in gene expression were reduced
for this component (Fig. 6C, 6D). In contrast, the Dlgt and WT
TIGR4 strains induced comparable changes to gene expression in
PC2, distinct from those induced by Pam2CSK4 and therefore by
FIGURE 5. Pneumococcal lipoproteins are important
determinants of TLR-induced NF-kB activation. (A)
Quantification of nuclear NF-kB p65 using MSD (arbitrary
units) for BMDMs from C57BL/6 WT and Myd88/trif 2/2
mice incubated for 1 h with Dlgt and TIGR4 S. pneumo-
niae (MOI of 5). Each symbol represents results for one
well, the bar represents median values, and the p value for
comparison of TIGR4 and Dlgt strains incubated with WT
BMDMs was obtained using a Mann–Whitney U test. (B)
Confocal immunofluorescence images of NF-kB RelA in
human MDM from five different donors stimulated for 2 h
with WT (TIGR4) or lipoprotein-deficient (Dlgt) S. pneu-
moniae (MOI 5 or 50) showing diminished nuclear trans-
location of RelA (pink nuclei) for cells incubated with the
Dlgt strain. (C) Quantitative image analysis of the median
(IQR) ratio of nuclear to cytoplasmic RelA staining (*p =
0.0079, Mann–Whitney U test).
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inference independent of TLR2 (Fig. 6C, 6E). This analysis is
consistent with the Venn diagram of qualitative transcriptional
responses to these stimuli, which showed that MDMs stimulated
with the Dlgt and TIGR4 strains shared increased expression of
320 genes that were not upregulated following specific TLR2
stimulation by Pam2CSK4 (Fig. 6B). Bioinformatic analysis of
the top 50 genes that reflected S. pneumoniae TLR2-dependent
responses in PC1 and TLR-2 independent responses in PC2 is
presented in Supplemental Fig. 1. Transcription factor binding site
enrichment analyses revealed the dominance of NF-kB–regulated
genes in PC1, associated with enrichment for proinflammatory
cytokines reflected by pathway and gene ontology analysis
(Supplemental Fig. 1). In contrast, TLR2-independent responses
to S. pneumoniae reflected in PC2 showed markedly less enrich-
ment for NF-kB–regulated genes, with modest enrichment for
genes associated with nucleosome and transcriptional regulation
instead. Taken together, these data suggest that the canonical in-
flammatory responses to TIGR4 are mediated by TLR2 and are
attenuated in response to the Dlgt strain. However, non-TLR2
transcriptional responses were largely comparable in MDMs
stimulated with either the Dlgt or TIGR4 strains.
The genes showing the greatest differences in expression be-
tween MDMs stimulated with Dlgt and TIGR4 strains included the
cytokines IL-23, IL-6, and IL-1b, and the chemokines CXCL1,
CXCL2, and CXCL3 (Supplemental Fig. 2A), and transcriptional
factor binding site analysis showed enrichment for regulation by
NF-kB (Table I) in keeping with the data shown in Fig. 5 and
Supplemental Fig. 1. Selected differences in expression of pro-
totypic inflammatory genes identified by microarray were vali-
dated by qPCR. IL-23, IL-6, and PTGS2 expression were all
significantly lower in macrophages stimulated with the Dlgt strain
compared with WT TIGR4, confirming the transcriptome results
FIGURE 6. Attenuated TLR2-associated macrophage transcriptional responses in response to lipoprotein-deficient S. pneumoniae. Comparison of MDM
genome-wide transcriptional responses from at least three donors after 4-h stimulation with Pam2CSK4, WT (TIGR4), or Dlgt S. pneumoniae. (A) Total
number of genes upregulated at least .2-fold. (B) Venn diagram of the overlap between the genes upregulated .2-fold by each stimulus. (C) PC analysis
showing quantitative differences in expression levels of cocorrelated gene signatures in the global gene expression profile. The graph plots PC1 and PC2,
responsible for the greatest differences, for each condition (data points represent mean6 SEM of$3 separate experiments). (D and E) The gene expression
heat map shows the transcriptional response (compared with unstimulated MDM) for the top 50 genes that contribute to PC1 (D) and PC2 (E).
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(Supplemental Fig. 2A–E). Although the microarray and qPCR
analysis showed no difference in TNF-a expression induced by
the two strains (Supplemental Fig. 2A, 2F), both TNF-a and IL-6
production by macrophages were attenuated in response to the
Dlgt strain (Supplemental Fig. 2G). Similarly, reduced levels of
IL-1b, IL-6, and TNF-a were present in supernatants from human
PBMCs stimulated with the Dlgt strain compared with TIGR4
(Table II).
Role of lipoproteins for inflammatory responses to
S. pneumoniae during infection
A mouse model was used to investigate the role of lipoproteins for
inflammatory responses to S. pneumoniae during lung infection.
As the Dlgt strain cannot replicate efficiently under in vivo con-
ditions and is highly attenuated in virulence (45), only a short-
term infection model could be used. To reduce differences in
bacterial CFU confounding the results, the experiments were
performed in the DpabB background, which is unable to replicate
during infection (47). Four hours after intranasal inoculation with
107 CFU, BALF TNF-a and IL-1b levels were raised in response
to the DpabB strain compared with the DpabB/Dlgt strain
(Fig. 7A, 7B) despite similar BALF CFU (5.14 and 5.16 log10
CFU/ml, respectively). BALF IL-6 levels were similar for both
strains, although in vitro IL-6 release by BMDMs was dependent
on TLR2 and reduced in response to the Dlgt strain (Fig. 7C,
Supplemental Fig. 3). Neither strain caused a significant increase
in BALF cellularity at this early time point (Fig. 7D).
IRAK-4–dependent release of protective proinflammatory
cytokines from human PBMCs is largely dependent on
lipoproteins
To further assess the clinical relevance of TLR-dependent in-
flammatory responses to lipoproteins, the WT TIGR4 and Dlgt
strains were incubated with PBMCs obtained from two humans
with IRAK-4 deficiency, and cytokine transcriptional and protein
responses were measured. High levels of TNF-a and IL-1b were
found in supernatants from healthy control PBMCs incubated with
WT TIGR4. In contrast, incubation of healthy control PBMCs
with the Dlgt strain or IRAK-42/2 PBMCs with either WT or Dlgt
TIGR4 resulted in similar reduced levels of TNF-a and IL-1b
(Fig. 8A, 8B). In these experiments, no significant PBMC IL-6
response was detected (Fig. 8C). qPCR demonstrated increased
expression of TNFa, IL1-b, and IL-6 by control PBMCs in re-
sponse to WT TIGR4, a response that was significantly attenuated
in PBMCs from IRAK-4–deficient individuals (Fig. 8D–F). In
contrast, there was no induction of IL-1b and IL-6 gene expression
by the Dlgt strain in either control or IRAK-4–deficient PBMCs
(Fig. 8E, 8F) and reduced TNF-a expression by control PBMCs
(Fig. 8D). Overall, these data show that important components of
the IRAK-4–dependent inflammatory response to S. pneumoniae
are considerably reduced in response to the Dlgt strain, indicating
that lipoproteins are likely to be major stimuli for IRAK-4–de-
pendent immune responses.
Discussion
S. pneumoniae infections cause a strong NF-kB–mediated proin-
flammatory response that is essential for host immunity but also
causes some of the important features of severe infection (2–4,
60). This inflammatory response has previously been shown to be
partially dependent on TLR2 (18, 19, 23, 24, 61). In addition,
TLR2 responses are required for Th17 and some humoral adaptive
immune responses (19, 28, 29). Identifying the S. pneumoniae
TLR2 ligands is important for our understanding of disease
pathogenesis and for the design of therapeutic manipulations
aimed at modifying inflammatory responses or improving humoral
and cellular immunity to S. pneumoniae. Although the cell wall
components PGN and LTA are proinflammatory S. pneumoniae
ligands thought to be recognized by TLR2 (33–35), recent evi-
dence suggests they may stimulate inflammatory responses by
TLR2-independent mechanisms (36–38). In contrast to the ex-
tensive data on PGN and LTA, the potential role of lipoproteins as
proinflammatory stimuli during S. pneumoniae infections has not
been characterized. We have now explored the role of lipoproteins
as S. pneumoniae proinflammatory ligands using the Dlgt strain
(45), which allows the effects of lipoproteins to be assessed in the
context of the whole bacterium rather than relying on purified
products.
Our results demonstrated that S. pneumoniae lipoproteins are
major contributors to the macrophage TLR- and NF-kB–mediated
inflammatory response. In theory, the effects of the Dlgt mutation
on the physiology of S. pneumoniae (45) could have confounded
these results, but control experiments demonstrated persistent
Table I. Transcription factor enrichment of gene expression differences
between MDMs stimulated with TIGR4 and Δlgt
Transcription
Factor
Background TFBS
Rate
Target TFBS
Rate Z-Scorea
RELA 0.0035 0.0103 26.16
NF-kB 0.0050 0.0118 22.11
REL 0.0081 0.0167 21.66
HLF 0.0049 0.0109 19.48
NFKB1 0.0020 0.0053 17.10
NFIL3 0.0033 0.0066 13.19
STAT1 0.0016 0.0038 12.10
Foxq1 0.0060 0.0100 11.71
Ar 0.0006 0.0017 10.32
aZ-scores of .10 are considered to indicate highly significant overrepresentation
of TFBS within the analyzed gene list.
TFBS, transcription factor binding site.
Table II. Mean (SEM) cytokine responses in pg/ml 4 h after incubation of PBMCs from five donors with the
TIGR4 wild-type and Dlgt S. pneumoniae strains
Cytokine
Conditions
p for TIGR4 vs. DlgtUnstimulated Pam2CSK4 TIGR4 Dlgt
IFN-g 34 (9.6) 94 (16) 56 (16) 38 (9.9) NS
IL-10 4.7 (1.2) 58 (25) 6.8 (1.7) 16 (10) NS
IL-12 3.1 (1.3) 9.8 (0.5) 10 (1.1) 6.5 (1.7) NS
IL-1b 30 (9.9) 1,410 (433) 7,040 (634) 3,260 (501) 0.0016
IL-6 127 (25) 3,340 (797) 245 (57) 98 (18) 0.040
IL-8 5,190 (1,180) 5,210 (715) 10,780 (1,220) 8,650 (1,220) NS
TNF-a 690 (202) 8,030 (2,160) 4,710 (965) 1,650 (392) 0.019
The p values are for comparisons of results obtained with the TIGR4 or Dlgt strains (unpaired t tests).
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decreases in macrophage inflammatory responses to the Dlgt strain
when live or nonreplicating (to control for bacterial CFU) bacteria
were used. The data obtained by the nonreplicating DpabB strains
could also have been confounded by the dual mutation in the Dlgt/
pabB strain compared with the DpabB strain; however, additional
control experiments also showed reduced inflammatory responses
to lipoprotein extracts or sonicated bacteria (to release cell wall
fragments) from the Dlgt strain compared with WT. Differences in
TNF-a responses to TIGR4 and Dlgt strains were lost for mac-
rophages from TLR2 mice and preserved for macrophages from
TLR4 mice. Of the surface structures that affect interactions with
the host, S. pneumoniae LTA has recently been shown not to affect
TLR2 responses (38), and we have shown no effect of the Dlgt
mutation on PGN structure and (in a previous publication) on
neutrophil killing of S. pneumoniae, a phenotype suggesting the
capsule is unaffected (45). Furthermore, two papers have shown
the capsule has limited effects on inflammation (62, 63), and,
although a third suggests capsule material can induce inflamma-
tory responses (64), these were measured at a much later time
point than our data and may be confounded by contamination of
capsule polysaccharide with cell wall or lipoprotein. Hence, it is
unlikely that the differences in inflammatory responses seen be-
tween WT and Dlgt strains were confounded by effects of the
mutation on bacterial physiology, PGN structure, or the capsule.
Complementing the Dlgt mutation would have been beneficial, but
for poorly understood reasons S. pneumoniae mutant strains can
be difficult to complement, and our attempts to complement the
Dlgt mutant failed (45). Instead, we used whole-genome se-
quencing and transfer of the mutation to another strain to link the
phenotypes seen to deletion of lgt. These results indicate that
lipoproteins are major TLR2 ligands for S. pneumoniae, similar to
results obtained with other Gram-positive pathogens (39, 40, 51, 65).
We used transcriptional arrays, qPCR, and supernatant cytokine
levels to confirm decreased expression of a variety of proin-
flammatory cytokines and chemokines for macrophages infected
with the Dlgt strain. There were some discrepancies between
transcriptional and protein level data with, for example, consis-
tently reduced levels of TNF-a protein in response to infection of
MDMs, BMDMs, and PBMCs despite little change in gene tran-
scription at the 4-h time point, which may reflect release of pre-
formed TNF-a. In addition, significant levels of IL-1b, IL-6, and
TNF-a were still produced by leukocytes in response to the Dlgt
strain, potentially reflecting inflammatory responses induced by
NOD2-mediated recognition of PGN and pneumolysin activation
of the inflammasome and/or TLR4 (16, 27, 36, 37, 66, 67). These
mechanisms combined with residual TLR2 activation may ex-
plain why the macrophage proinflammatory gene transcriptional
responses to the Dlgt strain were reduced rather than absent
compared with WT TIGR4. These results are also consistent with
published data showing more marked effects of MyD88 deficiency
than loss of individual TLRs on inflammatory response to S. pneu-
moniae in mice and humans (8, 11, 17, 19, 21). As TLR2 activation
increases TLR4-, pneumolysin-, andNOD2-dependent inflammatory
responses to S. pneumoniae (21, 26, 27), S. pneumoniae lipoproteins
may also increase inflammatory responses indirectly through these
other mechanisms of innate immune recognition.
The global assessment of macrophage responses by transcrip-
tional profiling significantly improves our understanding of key
interactions of the host with S. pneumoniae. S. pneumoniae caused
major changes in macrophage gene expression, with upregulation
of .900 genes in response to the WT TIGR4 strain. Many genes
showing large differences in expression between control macro-
phages and those infected with TIGR4 S. pneumoniae were
equally expressed in response to infection with the Dlgt strain.
However, the small proportion of genes with differences in ex-
pression between the WT and Dlgt strain was concentrated in the
transcriptional responses with the greatest upregulation in re-
sponse to S. pneumoniae (PC1), which also responded to
Pam2CSK4 stimulation. These data show that macrophage tran-
scriptional responses to S. pneumoniae are dominated by TLR2-
dependent genes that often require the presence of lipoproteins for
maximal stimulation, with a larger number of generally weaker
changes in expression of genes whose responses are TLR2 in-
dependent. The list of TLR2-dependent genes has a striking
preponderance for genes encoding important proinflammatory
proteins that bioinformatic analysis suggests are largely activated
by the NF-kB pathway, in keeping with the data showing reduced
FIGURE 7. Effects of lipoproteins during early lung infection. CD1
mice (n = 5–6) were inoculated intranasally with 1 3 107 CFU
TIGR4DpabB or Dlgt/pabB and BALF obtained at 4 h. BALF TNF-a (A),
IL-1b (B), and IL-6 (C) (PBS control data obtained during a separate in-
fection experiment) levels measured by ELISA. (D) BALF total cell count.
Each symbol represents results from a single mouse, and the bars medians.
The p values were obtained using Mann–Whitney U tests.
FIGURE 8. IRAK4-dependent production of proinflammatory cyto-
kines is largely lipoprotein dependent. PBMCs from three healthy vol-
unteers and two IRAK4-deficient patients were stimulated for 4 h with
TIGR4 or Dlgt S. pneumoniae (MOI 10). (A–C) Mean TNF-a (A), IL-1b
(B), and IL-6 (C) concentrations measured by ELISA in cell culture
supernatants. (D–F) qPCR of TNF-a (D), IL-1b (E), and IL-6 (F) gene
expression (relative to GAPDH). Each symbol represents results from
a single donor.
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NF-kB activation in response to the Dlgt strain. Our data contrast
with those showing that pneumolysin induced macrophage ex-
pression of very few genes encoding chemokines or cytokines (68).
The potential clinical relevance of S. pneumoniae lipoprotein-
dependent inflammation was assessed in a mouse model of
pneumonia, and using PBMCs from individuals with IRAK-4
deficiency. We were able to demonstrate that the rapid TNF-a
and IL-1b responses during early lung infection with S. pneu-
moniae were reduced in response to the Dlgt strain. Despite the
effect of lipoproteins on the IL-6 response in vitro, BALF IL-6
responses were similar for mice infected with the TIGR4 or Dlgt
strain. Potentially, differences in IL-6 levels could develop later in
infection, but as the Dlgt strain cannot maintain long-term infec-
tion in mouse models (45), it was not feasible to investigate this.
The striking susceptibility of children with IRAK-4 deficiency to
invasive S. pneumoniae infections demonstrates the vital impor-
tance of inflammatory responses for immunity to this pathogen
during childhood (5, 6, 9, 10), but the S. pneumoniae ligands re-
sponsible have not been identified. In mouse models of infection,
IL-1b, IL-6, and TNF-a are important protective cytokines during
S. pneumoniae infection (13–15), and we have now demonstrated
that expression of these cytokines by healthy controls was largely
dependent on lipoproteins. Importantly, WT PBMCs IL-1b, IL-6,
and TNF-a responses to the Dlgt strain were attenuated at the
transcriptional and (for IL-1b and TNF-a) protein level, similar to
the results for WT TIGR4 incubated with PBMCs obtained from
IRAK4-deficient subjects. Due to the limited number of donors
available, only two IRAK4-deficient subjects were available for
testing. Despite this, the results were highly consistent between
the two donors and suggest that lipoproteins are important ligands
driving IRAK-4–dependent inflammatory responses and therefore
protective immunity in children.
Overall, our data demonstrate that lipoproteins are major
S. pneumoniae TLR2 ligands that are required for the maximum
transcriptional response for many of the dominant macrophage
gene responses to S. pneumoniae, including induction of IRAK-4–
dependent protective cytokines. Specific targeting of bacterial
lipoprotein/TLR2 inflammatory responses could be a novel ther-
apeutic approach for enhancing cellular and humoral immune
responses to vaccines or, when combined with effective antibiotic
therapy, for improving the outcome of severe S. pneumoniae
infections.
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